HEADER LIPOPROTEIN 15-DEC-08 2KC3 TITLE NMR SOLUTION STRUCTURE OF COMPLETE RECEPTOR BINDING DOMAIN OF HUMAN TITLE 2 APOLIPOPROTEIN E COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOLIPOPROTEIN E; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 19-201; COMPND 5 SYNONYM: APO-E; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APOE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS APOE, LDLR, VLDLR, RECEPTOR BINDING DOMAIN, LIPID TRANSPORT, KEYWDS 2 ALZHEIMER DISEASE, CHYLOMICRON, DISEASE MUTATION, GLYCATION, KEYWDS 3 GLYCOPROTEIN, HDL, HEPARIN-BINDING, HYPERLIPIDEMIA, POLYMORPHISM, KEYWDS 4 SECRETED, TRANSPORT, VLDL, LIPOPROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.WANG,A.SIVASHANMUGAM REVDAT 2 16-MAR-22 2KC3 1 REMARK SEQADV REVDAT 1 14-APR-09 2KC3 0 JRNL AUTH A.SIVASHANMUGAM,J.WANG JRNL TITL A COMPLETE RECEPTOR BINDING DOMAIN OF HUMAN APOLIPOPROTEIN E JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1, CNS REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KC3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1000100935. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 0.05 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N; U REMARK 210 -70% 2H] HUMAN APOLIPOPROTEIN E REMARK 210 N-TERMINAL DOMAIN-1, 95% H2O/5% REMARK 210 D2O; 1 MM [U-100% 13C; U-100% REMARK 210 15N; U-30% 2H] HUMAN REMARK 210 APOLIPOPROTEIN E N-TERMINAL REMARK 210 DOMAIN-2, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 HN(CO)CA; 3D HN(COCA)CB; 3D 1H- REMARK 210 15N NOESY; 3D C(CO)NH; 3D H(CCO) REMARK 210 NH; 3D HCCH-TOCSY; 4D 15N-13C REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRDRAW, PIPP, NMRVIEW, REMARK 210 PROCHECKNMR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY AND LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 MET A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 10 23.01 -69.81 REMARK 500 1 GLU A 11 98.14 77.05 REMARK 500 1 LEU A 43 19.39 59.53 REMARK 500 1 SER A 53 -168.50 -118.60 REMARK 500 1 SER A 54 31.73 -91.41 REMARK 500 1 GLN A 55 -72.16 -69.01 REMARK 500 1 LEU A 82 66.39 -161.34 REMARK 500 1 THR A 83 139.05 45.57 REMARK 500 1 PRO A 84 58.50 -69.76 REMARK 500 1 VAL A 85 -76.35 -145.47 REMARK 500 1 ALA A 86 73.02 43.57 REMARK 500 1 GLU A 87 -74.79 -165.69 REMARK 500 1 MET A 125 -70.66 -112.69 REMARK 500 1 LEU A 126 -72.85 68.14 REMARK 500 1 GLN A 128 -168.69 -70.74 REMARK 500 1 ALA A 166 -96.42 -78.69 REMARK 500 1 ARG A 167 -85.76 175.42 REMARK 500 2 THR A 8 31.05 -83.18 REMARK 500 2 PRO A 12 52.05 -69.76 REMARK 500 2 GLN A 41 -169.30 -56.32 REMARK 500 2 THR A 42 -22.53 82.72 REMARK 500 2 SER A 54 30.40 -91.48 REMARK 500 2 GLN A 55 -71.71 -65.02 REMARK 500 2 LEU A 82 -75.45 -154.31 REMARK 500 2 THR A 83 150.16 175.63 REMARK 500 2 PRO A 84 60.34 -69.75 REMARK 500 2 VAL A 85 77.52 -172.00 REMARK 500 2 ALA A 86 61.89 -104.20 REMARK 500 2 GLU A 87 -75.70 -136.57 REMARK 500 2 MET A 125 -63.33 -90.35 REMARK 500 2 LEU A 126 105.31 60.48 REMARK 500 2 GLN A 128 -166.61 -64.46 REMARK 500 2 ALA A 166 -77.30 -94.18 REMARK 500 2 ARG A 167 -76.08 -179.91 REMARK 500 3 PRO A 10 24.23 -69.78 REMARK 500 3 GLU A 11 97.70 76.44 REMARK 500 3 THR A 42 105.13 -55.39 REMARK 500 3 LEU A 43 38.40 -91.44 REMARK 500 3 SER A 54 33.27 -91.79 REMARK 500 3 GLN A 55 -72.03 -67.66 REMARK 500 3 LEU A 82 -74.77 -76.07 REMARK 500 3 VAL A 85 -71.78 -90.53 REMARK 500 3 GLU A 87 -78.24 -125.72 REMARK 500 3 MET A 125 -63.26 -98.73 REMARK 500 3 LEU A 126 102.53 59.86 REMARK 500 3 GLN A 128 -75.06 -51.73 REMARK 500 3 THR A 130 -35.86 -165.13 REMARK 500 3 ALA A 166 -82.16 -76.23 REMARK 500 3 ARG A 167 -77.99 176.64 REMARK 500 4 THR A 8 43.78 -81.07 REMARK 500 REMARK 500 THIS ENTRY HAS 347 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6524 RELATED DB: BMRB REMARK 900 BACKBONE CHEMICAL SHIFTS FOR APOE(1-183) REMARK 900 RELATED ID: 1LPE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LDL RECEPTOR-BINDING DOMAIN OF HUMAN REMARK 900 APOLIPOPROTEIN E DBREF 2KC3 A 1 183 UNP P02649 APOE_HUMAN 19 201 SEQADV 2KC3 MET A 0 UNP P02649 EXPRESSION TAG SEQRES 1 A 184 MET LYS VAL GLU GLN ALA VAL GLU THR GLU PRO GLU PRO SEQRES 2 A 184 GLU LEU ARG GLN GLN THR GLU TRP GLN SER GLY GLN ARG SEQRES 3 A 184 TRP GLU LEU ALA LEU GLY ARG PHE TRP ASP TYR LEU ARG SEQRES 4 A 184 TRP VAL GLN THR LEU SER GLU GLN VAL GLN GLU GLU LEU SEQRES 5 A 184 LEU SER SER GLN VAL THR GLN GLU LEU ARG ALA LEU MET SEQRES 6 A 184 ASP GLU THR MET LYS GLU LEU LYS ALA TYR LYS SER GLU SEQRES 7 A 184 LEU GLU GLU GLN LEU THR PRO VAL ALA GLU GLU THR ARG SEQRES 8 A 184 ALA ARG LEU SER LYS GLU LEU GLN ALA ALA GLN ALA ARG SEQRES 9 A 184 LEU GLY ALA ASP MET GLU ASP VAL CYS GLY ARG LEU VAL SEQRES 10 A 184 GLN TYR ARG GLY GLU VAL GLN ALA MET LEU GLY GLN SER SEQRES 11 A 184 THR GLU GLU LEU ARG VAL ARG LEU ALA SER HIS LEU ARG SEQRES 12 A 184 LYS LEU ARG LYS ARG LEU LEU ARG ASP ALA ASP ASP LEU SEQRES 13 A 184 GLN LYS ARG LEU ALA VAL TYR GLN ALA GLY ALA ARG GLU SEQRES 14 A 184 GLY ALA GLU ARG GLY LEU SER ALA ILE ARG GLU ARG LEU SEQRES 15 A 184 GLY PRO HELIX 1 1 PRO A 12 SER A 22 1 11 HELIX 2 2 GLN A 24 VAL A 40 1 17 HELIX 3 3 GLN A 41 LEU A 43 5 3 HELIX 4 4 SER A 44 LEU A 52 1 9 HELIX 5 5 SER A 54 GLU A 79 1 26 HELIX 6 6 GLU A 88 ALA A 124 1 37 HELIX 7 7 GLU A 131 GLN A 163 1 33 HELIX 8 8 LEU A 174 LEU A 181 1 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1